Concentrix is trading at $25.00 (+6.07%) as the stock continues to recover from a volatile stretch triggered by its recent outlook revision.

  • Shares fell more than 20% following the June 29 earnings update, which included a significant cut to company guidance.
  • Today's move appears to be a continuation of the market's repricing process following the guidance reset, aided by a broader risk-on sentiment across equities.
  • There are no new company-specific announcements for July 15, with the stock showing a choppy rebound from its recent post-earnings lows.